🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted steps to tackle household expense issues" in the upcoming Budget.

During an interview with media outlets, she noted that reducing price rises is a joint responsibility of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Energy Bill Interventions

It is understood the administration could take action to bring down energy bills, for instance by reducing the current 5% rate of value-added tax applied on energy supplies.

An additional option is to reduce some of the policy costs presently included in household expenses.

Fiscal Constraints and Analyst Predictions

The government will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for such measures.

The view from most economists is that Reeves will have to announce tax increases or budget cuts in order to meet her voluntary fiscal targets.

Previously on the same day, estimates indicated there was a £22bn shortfall for the chancellor to fill, which is at the lower end of projections.

"It is a collective job between the Bank of England and the government to further reduce some of the causes of inflation," the Chancellor stated to reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Commitments and International Concerns

While a great deal of the focus has been on likely tax increases, the Treasury chief said the most recent figures from the OBR had not changed her pledge to election pledges not to increase rates on income tax, VAT or social security contributions.

She blamed an "uncertain global environment" with increasing geopolitical and trade tensions for the fiscal revenue measures, probably to be focused on those "most able to pay."

International Trade Tensions

Referring to apprehensions about the UK's trade ties with China she said: "The UK's security interests always are paramount."

Last week's declaration by China to tighten trade restrictions on rare earths and other resources that are key for high-technology manufacturing led American leader Donald Trump to propose an further 100% tariff on goods from China, increasing the possibility of an all-out commercial conflict between the two largest economies.

The American finance chief described China's decision "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the US offer to join its conflict with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "bad for the world economy and causes additional obstacles."

"In my view there are fields where we need to address China, but there are also significant chances to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to get that equilibrium appropriate."

The chancellor also stated she was working with other major economies "on our own critical minerals approach, so that we are less reliant."

Health Service Medicine Pricing and Investment

The Chancellor also acknowledged that the price the National Health Service spends on medicines could rise as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or scrapping investments in the United Kingdom, with some attributing the modest returns they are obtaining.

Last month, the government science advisor said the cost the health service pays for drugs would must rise to prevent companies and pharmaceutical investment departing from the UK.

The Chancellor told the BBC: "It has been observed due to the pricing regime, that medical research, new drugs have not been provided in the UK in the way that they are in other continental states."

"The objective is to ensure that individuals getting care from the NHS are able to receive the finest life-saving treatments in the world. And so we are reviewing all of that, and... seeking to secure increased capital into the UK."